Cyclacel
Investors & Media

News

All Releases
View Summary Cyclacel Pharmaceuticals to Present at 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014
PDF 10.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Provides Update on Its Clinical Development Plan of Sapacitabine for Myelodysplastic Syndromes (MDS)
May 31, 2014
PDF 12.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Webcast Institutional Investor and Analyst Presentation on Clinical Development Plan of Sapacitabine for MDS
May 28, 2014
PDF 11.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results
May 13, 2014
PDF 57.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Release 2014 First Quarter Financial Results
May 6, 2014
PDF 13.1 KB Add to Briefcase
View Summary New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations and Combination Treatments
May 5, 2014
PDF 14.7 KB Add to Briefcase
View Summary Independent Investigators Present Non-Clinical Data Providing Rationale for Sapacitabine Combination Treatment With Bcr-Abl Inhibitors in CML
Apr 10, 2014
PDF 15.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. Announces Closing of $10 Million Underwritten Offering
Apr 9, 2014
PDF 13.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces $10 Million Underwritten Offering
Apr 4, 2014
PDF 13.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 3, 2014
PDF 13.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
Mar 25, 2014
PDF 64.6 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2013 Financial Results
Mar 13, 2014
PDF 10.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference
Feb 3, 2014
PDF 10.7 KB Add to Briefcase
View Summary Cyclacel Reviews 2013 Achievements and Announces Key Business Objectives for 2014
Jan 13, 2014
PDF 18.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2014 Conference
Jan 6, 2014
PDF 11.9 KB Add to Briefcase
  2013 ASH 682-06 MDS Poster
Dec 9, 2013
PDF 416.5 KB Add to Briefcase
View Summary Cyclacel Reports New Phase 2 Data of Sapacitabine for MDS at ASH
Dec 9, 2013
PDF 19.7 KB Add to Briefcase
View Summary Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Nov 25, 2013
PDF 13.2 KB Add to Briefcase
View Summary Cyclacel Reports Third Quarter 2013 Financial Results
Nov 12, 2013
PDF 26.8 KB Add to Briefcase
View Summary Researchers to Present New Phase 2 Data on Sapacitabine as a Treatment for Patients With MDS at ASH Annual Meeting
Nov 7, 2013
PDF 16.6 KB Add to Briefcase
Showing 61-80 of 339 Page: 1 2 3 4 5 6 7 8 ... 17  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
Investors & Media